Journal of magnetic resonance imaging : JMRI · 2026
A Mixed Methods Study of Anxiety and Patient Perception of Safety in Contrast-Enhanced MRI.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alsharif Walaa, Gareeballah Awadia, Alahmadi Ghaida, Iskander Basma, Alahmadi Raghad, Alrehaily Emad, Alhazmi Fahad H, Qurashi Abdulaziz A, Aldahery Shrooq, Alshamrani Khalid M, Alahmadi Adnan, Alshoabi Sultan, Alsaedi Amirah, Elkady Reem
Аннотация
BACKGROUND: Contrast administration may contribute to patient anxiety and safety concerns during magnetic resonance imaging (MRI), yet patient experiences specific to contrast-enhanced MRI (CE-MRI) examination remain underexplored.
PURPOSE: To explore patients' experiences during CE-MRI examination, focusing on anxiety levels and safety perceptions.
STUDY TYPE: Questionnaire-based study with follow-up patient interviews.
SUBJECTS: Two hundred and three adult patients undergoing CE-MRI in public hospitals; 28 participated in follow up interviews.
FIELD STRENGTH/SEQUENCE: 1.5 Tesla/standardized MRI scanning protocols across multiple body regions comprised 6-17 sequences per examination, with total table times ranging from 30 to 50 min, depending on the anatomical region examined.
ASSESSMENT: A structured questionnaire consisted of 31 items covering demographic characteristics, scan related information, experience with the CE-MRI examination, including information received, and anxiety assessment before, during, and after the CE-MRI examination using a four-point Likert scale. Following the CE-MRI examination, 28 patients from this original cohort participated in semi-structured interviews to explore their anxiety levels and perceptions of safety during the examination.
STATISTICAL TEST: Quantitative data were analyzed using SPSS, and a p value < 0.05 was considered significant. While qualitative data were analyzed thematically using NVivo software.
RESULTS: Forty-six percent of patients reported increased anxiety during contrast administration, and 26.1% rated the information provided about the examination unclear. It was found that 35% felt the examination did not meet their expectations based on the information given. Anxiety was more prevalent among females (Mean = 1.71), younger patients (Mean = 2.04), and those with higher education levels (Mean = 1.96). Qualitative findings identified key anxiety triggers, including sensory discomfort, fear of unknown outcomes, and poor timing or poor clarity of information. Empathetic communication and clarity were perceived as essential anxiety-reducing factors. Notably, anxiety levels significantly decreased after the examination (χ2 = 24.955).
DATA CONCLUSION: Anxiety levels were influenced by sex, age, education level, the provided information, and the quality of communication.
EVIDENCE LEVEL: 4.
STAGE OF TECHNOLOGY EFFICACY: Stage 3 (Diagnostic Thinking).
PURPOSE: To explore patients' experiences during CE-MRI examination, focusing on anxiety levels and safety perceptions.
STUDY TYPE: Questionnaire-based study with follow-up patient interviews.
SUBJECTS: Two hundred and three adult patients undergoing CE-MRI in public hospitals; 28 participated in follow up interviews.
FIELD STRENGTH/SEQUENCE: 1.5 Tesla/standardized MRI scanning protocols across multiple body regions comprised 6-17 sequences per examination, with total table times ranging from 30 to 50 min, depending on the anatomical region examined.
ASSESSMENT: A structured questionnaire consisted of 31 items covering demographic characteristics, scan related information, experience with the CE-MRI examination, including information received, and anxiety assessment before, during, and after the CE-MRI examination using a four-point Likert scale. Following the CE-MRI examination, 28 patients from this original cohort participated in semi-structured interviews to explore their anxiety levels and perceptions of safety during the examination.
STATISTICAL TEST: Quantitative data were analyzed using SPSS, and a p value < 0.05 was considered significant. While qualitative data were analyzed thematically using NVivo software.
RESULTS: Forty-six percent of patients reported increased anxiety during contrast administration, and 26.1% rated the information provided about the examination unclear. It was found that 35% felt the examination did not meet their expectations based on the information given. Anxiety was more prevalent among females (Mean = 1.71), younger patients (Mean = 2.04), and those with higher education levels (Mean = 1.96). Qualitative findings identified key anxiety triggers, including sensory discomfort, fear of unknown outcomes, and poor timing or poor clarity of information. Empathetic communication and clarity were perceived as essential anxiety-reducing factors. Notably, anxiety levels significantly decreased after the examination (χ2 = 24.955).
DATA CONCLUSION: Anxiety levels were influenced by sex, age, education level, the provided information, and the quality of communication.
EVIDENCE LEVEL: 4.
STAGE OF TECHNOLOGY EFFICACY: Stage 3 (Diagnostic Thinking).